Approval · Notice of Compliance 4098 · 1997
URSOFALK: Notice of Compliance 4098
Issued August 12, 1997
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 4098
- Date
- August 12, 1997
- Company
- Axcan Pharma Inc.Mont St-Hilaire, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Therapeutic class
- Litholytic agent, cholestatic liver agent
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| URSOFALK | 01945254 | Cancelled Post Market |
Medicinal ingredients
- URSODIOL 250 MG per CAP